Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions.

Awasthi S, Sharma A, Wong K, Zhang J, Matlock EF, Rogers L, Motloch P, Takemoto S, Taguchi H, Cole MD, Lüscher B, Dittrich O, Tagami H, Nakatani Y, McGee M, Girard AM, Gaughan L, Robson CN, Monnat RJ Jr, Harrod R.

Mol Cell Biol. 2005 Jul;25(14):6178-98.

2.

Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity.

Michael B, Nair AM, Datta A, Hiraragi H, Ratner L, Lairmore MD.

Virology. 2006 Oct 25;354(2):225-39. Epub 2006 Aug 4.

3.

Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.

Romeo MM, Ko B, Kim J, Brady R, Heatley HC, He J, Harrod CK, Barnett B, Ratner L, Lairmore MD, Martinez E, Lüscher B, Robson CN, Henriksson M, Harrod R.

Virology. 2015 Feb;476:271-88. doi: 10.1016/j.virol.2014.12.008. Epub 2015 Jan 5.

4.

Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.

Watanabe M, Nakahata S, Hamasaki M, Saito Y, Kawano Y, Hidaka T, Yamashita K, Umeki K, Taki T, Taniwaki M, Okayama A, Morishita K.

J Virol. 2010 Jul;84(14):6966-77. doi: 10.1128/JVI.00073-10. Epub 2010 May 5.

5.

Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes.

Michael B, Nair AM, Hiraragi H, Shen L, Feuer G, Boris-Lawrie K, Lairmore MD.

Retrovirology. 2004 Nov 23;1:39.

7.

Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells.

Sinha-Datta U, Horikawa I, Michishita E, Datta A, Sigler-Nicot JC, Brown M, Kazanji M, Barrett JC, Nicot C.

Blood. 2004 Oct 15;104(8):2523-31. Epub 2004 Jun 29.

8.

HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication.

Nicot C, Dundr M, Johnson JM, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T, Franchini G.

Nat Med. 2004 Feb;10(2):197-201. Epub 2004 Jan 18.

9.

HTLV-1 p30II: selective repressor of gene expression.

Green PL.

Retrovirology. 2004 Nov 24;1:40.

10.
11.

MYC recruits the TIP60 histone acetyltransferase complex to chromatin.

Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM, Livingston DM, Amati B.

EMBO Rep. 2003 Jun;4(6):575-80.

14.

HTLV-1 and associated adult T-cell leukemia/lymphoma.

Mahieux R, Gessain A.

Rev Clin Exp Hematol. 2003 Dec;7(4):336-61. Review.

PMID:
15129647
15.

Tip60 is a cell-type-specific transcriptional regulator.

Hlubek F, Löhberg C, Meiler J, Jung A, Kirchner T, Brabletz T.

J Biochem. 2001 Apr;129(4):635-41.

16.

Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells.

Santiago F, Clark E, Chong S, Molina C, Mozafari F, Mahieux R, Fujii M, Azimi N, Kashanchi F.

J Virol. 1999 Dec;73(12):9917-27.

17.

[HTLV-I and leukemogenesis].

Yasunaga J, Matsuoka M.

Uirusu. 2006 Dec;56(2):241-9. Review. Japanese.

18.

Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples.

Nicot C, Mahieux R, Takemoto S, Franchini G.

Blood. 2000 Jul 1;96(1):275-81.

19.

Molecular mechanisms of regulation of HTLV-1 gene expression and its association with leukemogenesis.

Yoshida M, Inoue J, Fujisawa J, Seiki M.

Genome. 1989;31(2):662-7.

PMID:
2698836
20.

Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2.

de La Fuente C, Santiago F, Chong SY, Deng L, Mayhood T, Fu P, Stein D, Denny T, Coffman F, Azimi N, Mahieux R, Kashanchi F.

J Virol. 2000 Aug;74(16):7270-83.

Supplemental Content

Support Center